Table 1 Baseline characteristics in the study group
Variable | Results |
|---|---|
Age(y), median (min, max) | 58 (20–85) |
Age at diagnosis (y), median (min, max) | 53 (9–85) |
Gender, n (%) | |
Male | 52 (57%) |
Female | 39 (43%) |
Phenotype, n (%) | |
Obstructive | 49 (54%) |
Nonobstructive | 42 (46%) |
NYHA class, n (%) | |
I | 22 (24.2%) |
II | 49 (53.8%) |
III | 19 (20.9%) |
IV | 1 (1.1%) |
Systemic hypertension, n (%) | 52 (61.9%) |
Diabetes, n (%) | 12 (14.3%) |
Chronic Kidney disease, n (%) | 21 (25%) |
ICD, n (%) | 7 (8.1%) |
Pacemaker, n (%) | 10 (11.6%) |
Pulmonary hypertension, n (% of measured) | 24 (34%) |
Rhythm n (%) | |
Sinus rhythm | 67 (73.6%) |
Atrial fibrillation | 9 (9.9%) |
Other | 15 (16.5%) |
BNP (pg/ml), median (min,max) | 296 (10–3999) |
Coronary artery disease, n (%) | 8 (12.1%) |